Varda Space Industries · 16 hours ago
Analytical Scientist
Varda is a company focused on accelerating the development of commercial space infrastructure. They are seeking a highly motivated Analytical Scientist to improve therapeutics with microgravity, shaping Varda’s product culture and contributing to the establishment of the low earth orbit economy.
AerospaceManufacturingProduct Design
Responsibilities
Develop, optimize and validate analytical methods for characterizing drug substances and drug products
Carry out hands-on experiments in the lab and working with external testing sites to fully characterize drug substances and drug products
Collaborate closely with product development, formulation sciences, and broader engineering groups to drive drug development activities
Author relevant documents such as methods, protocols, validation reports, and regulatory filings as needed
Qualification
Required
M.S. or Ph.D. in Analytical Chemistry (or similar field such as Chemistry, Biochemistry, Chemical Engineering, Materials Science or related fields)
Preferred
Experience with UV, DLS, DSF, NMR, CD, FTIR, Raman, and particle sizing technologies
Experience with chromatographic and affinity-based methods (HPLC/UPLC, LC-MS/MS, SEC-MALS, GC, CE-SDS, icIEF, SDS-PAGE)
Track record of method development as demonstrated by publications in peer-reviewed journals, IND/BLA/NDA filings, and presentations at scientific conferences
Experience as the responsible engineer or technical owner of projects across project lifecycle
Benefits
Exciting team of professionals at the top of their field working by your side
Equity in a fully funded space startup with potential for significant growth (interns excluded)
401(k) matching (interns excluded)
Unlimited PTO (interns excluded)
Health insurance, including Vision and Dental
Lunch and snacks provided on site every day. Dinners provided twice a week.
Maternity / Paternity leave (interns excluded)
Company
Varda Space Industries
Varda is building the infrastructure for a thriving orbital economy, from in-orbit pharmaceutical processing to reliable and economical reentry capsules.
Funding
Current Stage
Growth StageTotal Funding
$328.02MKey Investors
Alumni VenturesCaffeinated CapitalKhosla Ventures
2025-07-10Series C· $187M
2024-12-19Series C
2024-04-05Series B· $90M
Recent News
Business Insider
2025-12-25
2025-12-17
Company data provided by crunchbase